News

Expand filters

Filters

Locations

Showing 1 - 3 out of 3 results

News

FOX 4: FDA Removes Warning Label From Hormone Replacement Therapy

Bret Gordon, DO, OB-GYN division chair at Saint Luke's Women's Health South, weighs in on what this means for women.

News

KCTV: Early On-Set Breast Cancer and the Importance of Early Detection

While the mortality rate for breast cancer in the U.S. has significantly declined from its peak in 1989, incidence among younger women has steadily increased each year since 2001, according to the American Cancer Society.

Patient Stories

Fairway Man Becomes First Saint Luke’s Patient to Receive Targeted Radiation Therapy

All eyes were on Dana Boucher, 67, after he received his first dose of LUTATHERA®, a targeted radiation treatment, to treat his neuroendocrine cancer.

“There must have been a dozen people outside my hospital room at any given time,” Dana says. “Since I was the first patient at Saint Luke’s to undergo LUTATHERA therapy, doctors, nurses, and hospital administrators were all interested to see how I was doing.”